Insider Trading History of Dp Vi Associates, L.p.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Dp Vi Associates, L.p. since 2006. The trader's CIK number is 1298034. At the time of the last reporting, Dp Vi Associates, L.p. was the 10% Owner of Alimera Sciences Inc. (stock ticker symbol ALIM). Also see all insider trading activities at Alimera Sciences Inc.

Note that in the past DP VI Associates, L.P. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Somaxon Pharmaceuticals, Inc. (SOMX) by Dp Vi Associates, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 SOMX 0 $0 12,918 $171,485 0 $0

Yearly summary of insider trading at Vanda Pharmaceuticals Inc. (VNDA) by Dp Vi Associates, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 VNDA 0 $0 12,900 $330,498 0 $0

Yearly summary of insider trading at Alimera Sciences Inc (ALIM) by Dp Vi Associates, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 ALIM 0 $0 6,914 $55,588 0 $0


Insider trading activities at 3 companies by Dp Vi Associates, L.p.:

1. Somaxon Pharmaceuticals, Inc. (SOMX)

2. Vanda Pharmaceuticals Inc. (VNDA)

3. Alimera Sciences Inc (ALIM)

Table 1. Insider trading of Somaxon Pharmaceuticals, Inc. (SOMX) by Dp Vi Associates, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-12-21 SOMX Sale 6,459 13.52 87,325
2006-09-18 SOMX Sale 6,459 13.03 84,160

Table 2. Insider trading of Vanda Pharmaceuticals Inc. (VNDA) by Dp Vi Associates, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-12-12 VNDA Sale 12,900 25.62 330,498

Table 3. Insider trading of Alimera Sciences Inc (ALIM) by Dp Vi Associates, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-06-02 ALIM Sale 6,914 8.04 55,588

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dp Vi Associates, L.p. (10% Owner of Alimera Sciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.